LncRNA PVT1 promotes strong stemness and endothelial progenitor cell characteristics in renal carcinoma stem cells
Open Access
- 2 August 2023
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 37 (9) , e23118
Abstract
Renal cancer stem cells (RCSCs) derived from clear cell renal cell carcinoma (ccRCC) tissues with higher microvessel density (MVD) have strong stemness and endothelial progenitor cells‐like (EPCs‐like) characteristics. A high level of lncRNA PVT1 expression is essential for simultaneously retaining strong RCSC stemness and EPCs‐like characteristics. PVT1 binds with TAZ protein and prevents its phosphorylation, which promotes RCSC stemness. Moreover, RCSCs support endothelial differentiation and angiogenesis, which are mediated via the PVT1/miR‐15b/KDR axis. This report provides insight into the determinants of RCSC impact on stemness and highlights the critical role of RCSC in angiogenesis. The presented findings suggest that targeting RCSC through PVT1 expression may be a new treatment strategy for ccRCC.Keywords
Funding Information
- National Natural Science Foundation of China (82172000, 81971135)
This publication has 31 references indexed in Scilit:
- Benefits of pazopanib over sunitinib for renal cell carcinomaThe Lancet Oncology, 2016
- Tumor cell vascular mimicry: Novel targeting opportunity in melanomaPharmacology & Therapeutics, 2016
- Unique features of long non-coding RNA biogenesis and functionNature Reviews Genetics, 2015
- Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2Hepatology, 2014
- Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinomaBritish Journal of Cancer, 2014
- SnapShot: Tumor AngiogenesisCell, 2012
- Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic NicheCancer Research, 2011
- The cancer stem cell: premises, promises and challengesNature Medicine, 2011
- Identification of a tumor‐initiating stem cell population in human renal carcinomasThe FASEB Journal, 2008
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and AngiogenesisJournal of Clinical Oncology, 2008